Guardant Health Net Income increased by 12.8% to -$112.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.8%, from -$95.16M to -$112.08M. Over 4 years (FY 2021 to FY 2025), Net Income shows relatively stable performance with a 2.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$97.58M | -$107.53M | -$72.31M | -$123.23M | -$229.43M | -$161.99M | -$139.93M | -$133.53M | -$72.77M | -$86.10M | -$187.04M | -$114.99M | -$102.63M | -$107.75M | -$111.01M | -$95.16M | -$99.90M | -$92.73M | -$128.49M | -$112.08M |
| QoQ Change | — | -10.2% | +32.8% | -70.4% | -86.2% | +29.4% | +13.6% | +4.6% | +45.5% | -18.3% | -117.2% | +38.5% | +10.7% | -5.0% | -3.0% | +14.3% | -5.0% | +7.2% | -38.6% | +12.8% |
| YoY Change | — | — | — | — | -135.1% | -50.7% | -93.5% | -8.4% | +68.3% | +46.8% | -33.7% | +13.9% | -41.0% | -25.1% | +40.7% | +17.2% | +2.7% | +13.9% | -15.8% | -17.8% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | -$95.16M | -$99.90M | -$92.73M | -$128.49M | -$112.08M |
| Total | -$95.16M | -$99.90M | -$92.73M | -$128.49M | -$112.08M |